Advanced Enzyme Tech per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹14.82₹15.08₹11.72₹11.92₹9.45
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹14.81₹15.06₹11.71₹11.92₹9.45
₹145.81₹145.81₹127.00₹118.41₹110.45
₹66.98₹66.63₹56.93₹55.79₹48.35
—₹14.01₹12.74₹12.64₹12.55
₹9.33₹9.33₹9.63₹8.85₹9.14
—₹5.34₹5.28₹5.07₹1.12
11.211.211.211.211.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ADVENZYMES₹264.15

Advanced Enzyme Tech Ltd.

· Pharma & Health
₹ CrorePeersAARTIPHARMAARTIDRUGSAGARWALEYEAKUMSALIVUSAPLLTDCORONAHCGMcap ₹2,956 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS9.4511.9211.7215.0814.82
Diluted EPS9.4511.9211.7115.0614.81
Book Value per Share110.45118.41127.00145.81145.81
Revenue per Share48.3555.7956.9366.6366.98
Cash Flow per Share12.5512.6412.7414.01—
Free Cash Flow per Share9.148.859.639.339.33
Dividends per Share1.125.075.285.34—
Shares Outstanding (cr)11.211.211.211.211.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.